
Vitamin / mineral
Vitamin D
Rickets and osteomalacia (in marked deficiency); Fracture prevention in the general population — no benefit shown

Goals
Explore vitamin, mineral, supplement and peptide guides. Compare what has been studied for this goal and what remains uncertain.
Explore relevance, evidence and limitations together.
Showing 4 compounds

Vitamin / mineral
Rickets and osteomalacia (in marked deficiency); Fracture prevention in the general population — no benefit shown
Vitamin / mineral
Bone density in older adults (supplements) — clinical significance uncertain; Fracture prevention in older adults (calcium + vitamin D); Fracture prevention in community-dwelling postmenopausal women — no benefit shown
Vitamin / mineral
Clinical fracture in postmenopausal or osteoporotic people; Vertebral fracture and bone mineral density — no benefit shown
Vitamin / mineral
Bone density (MK-7, postmenopausal women); Fracture prevention (postmenopausal/osteoporotic) — not certain
Inclusion is not a recommendation. Findings apply to the studied outcome and population; negative findings are also listed. See each peptide guide for its medicine or research status.
A change in bone density is not the same as a reduction in fractures. Studies of calcium and vitamin D for fracture prevention have produced mixed findings; baseline status and the population studied matter. [1]
| Evidence | Compound | Outcome studied |
|---|---|---|
| AStrong | Vitamin D | Rickets and osteomalacia (in marked deficiency) |
| CLimited | Calcium | Bone density in older adults (supplements) — clinical significance uncertain |
| CLimited | Vitamin K and K1 | Clinical fracture in postmenopausal or osteoporotic people |
| CLimited | Vitamin K2 | Bone density (MK-7, postmenopausal women) |
Bone health and joint pain are separate goals. This page covers bone-density and fracture findings for calcium and vitamins D and K. Collagen, glucosamine and other joint-pain topics are in the joint guide. Treating a deficiency is not equivalent to preventive supplementation for everyone.
Calcium is a major component of bone, and vitamin D supports calcium absorption and mineralization. Correcting a deficiency differs from adding a supplement when intake is adequate. NIH ODS explains that calcium and vitamin D trials do not show identical fracture outcomes across populations. Age, baseline intake, vitamin D status and whether people live in an institution or the community affect interpretation. [1] [2]
A strong grade for a nutrient’s established biological role should not be interpreted as a need for higher intake in everyone. Deficiency, diagnosed osteoporosis and general prevention are separate questions and may require different approaches.
An increase in bone mineral density does not establish an equally large reduction in fractures. Falls, age and other health conditions also influence fracture risk. Some studies summarized by NIH ODS report small density changes without consistent fracture findings. Keep the actual outcome in view when reading vitamin K, calcium and vitamin D cards. [1]
“Bone health” alone is not an adequate endpoint. Did the study measure fractures, density or only a blood marker? How long did it last, and what was participants’ baseline risk? Those distinctions can explain why findings for one supplement appear contradictory.
Calcium from foods, supplements and some medicines contributes to total intake. Several products containing the same ingredient can increase intake unnoticed. NIH ODS discusses gas or constipation, interactions with medicines and limits on high intake. Excess vitamin D can also raise blood calcium and cause harm. [1] [2]
For example, someone taking both a multivitamin and a “bone support” preparation needs to consider both labels. This is not a personal dose calculation or an osteoporosis treatment recommendation. Replacing an osteoporosis medicine with a vitamin differs from addressing inadequate dietary intake; the guide keeps those decisions separate.
The VITAL fracture analysis followed 25,871 midlife and older adults for a median 5.3 years. Vitamin D did not significantly reduce total fractures (hazard ratio 0.98; 95% confidence interval 0.89–1.08). Participants were not selected for vitamin D deficiency, low bone density or osteoporosis. This does not mean treating marked deficiency is unnecessary; it shows that extra supplementation for general-population prevention is a different question. [3]
NIAMS considers nutrition, tailored exercise, fall prevention and medication when needed together in osteoporosis care. Balance and muscle strength also matter. Exercise needs safe adaptation in osteoporosis; one vitamin cannot replace the whole care plan. [4]
A reader with low bone density and a reader with painful joints are asking about different outcomes. The latter belongs in the joint guide. Keeping fractures, density and blood markers in separate rows exposes differences hidden by the broad marketing term bone support.
Previous fractures, height loss, falls and long-term glucocorticoid use matter in assessment. History and risk guide decisions about bone-density measurement and treatment. A blood calcium result alone does not replace an osteoporosis assessment. [4]
| Outcome of interest | Relevant research | Interpretation limit |
|---|---|---|
| Marked deficiency | Vitamin D/calcium assessment | Separate from general prevention |
| Bone density | Calcium and vitamin K | Not synonymous with fewer fractures |
| Population fracture prevention | VITAL vitamin D findings | Not selected for deficiency/osteoporosis |
| Osteoporosis treatment | Whole care plan | Supplements alone do not replace medicines |
Biological necessity and treating deficiency differ from extra supplementation in a generally replete population. Check who was studied.
That proportion cannot be assumed. Fractures need separate measurement, with falls and other risks considered too.
Updated
This content is for information only and is not medical advice. It does not recommend doses, products or vendors. Talk to your clinician before making any health decision.